Rallybio Corporation (RLYB) Tops Q4 EPS by 55c

Rallybio Corporation (NASDAQ: RLYB) reported Q4 EPS of $0.25, $0.55 better than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Rallybio Corporation (RLYB) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Goldman Sachs sees China retail sales growth staying weak